AKT1 and ovarian carcinoma: Our data suggested that PAK5 regulated the activation process of the PI3K/AKT pathway; in other words, PI3K/AKT signaling might underlie the molecular mechanism that contributed to PAK5-mediated ovarian cancer progression.